Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Carol Deminie
In Vitro Resistance Profile of the Human Immunodeficiency Virus Type 1 Protease Inhibitor BMS-232632
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Estimate of the Frequency of Human Immunodeficiency Virus Type 1 Protease Inhibitor Resistance Within Unselected Virus Populations in Vitro
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Human Immunodeficiency Virus Type 1 Protease-Correlated Cleavage Site Mutations Enhance Inhibitor Resistance
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Association of a Novel Human Immunodeficiency Virus Type 1 Protease Substrate Cleft Mutation, L23I, With Protease Inhibitor Therapy and in Vitro Drug Resistance
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease Following Different Protease Inhibitor Treatments
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Activities of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor Nelfinavir Mesylate in Combination With Reverse Transcriptase and Protease Inhibitors Against Acute HIV-1 Infection in Vitro.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Polymorphism of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Gene and Response of HIV-1-Infected Patients to a Protease Inhibitor
Journal of Clinical Microbiology
Microbiology
Nucleoside Analog 1592U89 and Human Immunodeficiency Virus Protease Inhibitor 141W94 Are Synergistic in Vitro
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Variant Human Immunodeficiency Virus Type 1 Proteases and Response to Combination Therapy Including a Protease Inhibitor
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
